Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parivash Nourjah

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Substance Abuse|March 11, 2021
"<i>One size does not fit all</i>" and other lessons learned from grants for implementation of the AHRQ medication assisted treatment for opioid use disorder in rural primary careParivash Nourjah, Elizabeth Kato
AJR. American Journal of Roentgenology|February 25, 2006
Deaths attributed to X-ray contrast media on U.S. death certificatesDiane K Wysowski, Parivash Nourjah
Archives of Dermatology|May 18, 2005
Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART programAllen Brinker, Cynthia Kornegay, Parivash Nourjah
Archives of Internal Medicine|July 11, 2007
Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory actionDiane K Wysowski, Parivash Nourjah, Lynette Swartz
Pharmacoepidemiology and Drug Safety|November 19, 2005
Estimates of acetaminophen (Paracetomal)-associated overdoses in the United StatesParivash Nourjah, Syed Rizwanuddin Ahmad, Claudia Karwoski, et al.
The American Journal of Medicine|April 12, 2003
Troglitazone-induced liver failure: a case studyDavid J Graham, Lanh Green, John R Senior, et al.
Journal of the American Pharmacists Association : Japha|July 26, 2008
Drug-risk communication to pharmacists: assessing the impact of risk-minimization strategies on the practice of pharmacyLauren Y Lee, Cindy M Kortepeter, Mary E Willy, et al.
The Annals of Pharmacotherapy|March 10, 2005
Factors associated with celecoxib and rofecoxib utilizationNigel S B Rawson, Parivash Nourjah, Stella C Grosser, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|August 5, 2005
Risk factors for prolonged QTc among US adults: Third National Health and Nutrition Examination SurveyStephen R Benoit, Aaron B Mendelsohn, Parivash Nourjah, et al.
Pharmacoepidemiology and Drug Safety|January 1, 2009
Emergency department visits attributed to selected analgesics, United States, 2004-2005Mary Willy, Judith P Kelly, Parivash Nourjah, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Substance Abuse|March 11, 2021
"<i>One size does not fit all</i>" and other lessons learned from grants for implementation of the AHRQ medication assisted treatment for opioid use disorder in rural primary careParivash Nourjah, Elizabeth Kato
AJR. American Journal of Roentgenology|February 25, 2006
Deaths attributed to X-ray contrast media on U.S. death certificatesDiane K Wysowski, Parivash Nourjah
Archives of Dermatology|May 18, 2005
Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART programAllen Brinker, Cynthia Kornegay, Parivash Nourjah
Archives of Internal Medicine|July 11, 2007
Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory actionDiane K Wysowski, Parivash Nourjah, Lynette Swartz
Pharmacoepidemiology and Drug Safety|November 19, 2005
Estimates of acetaminophen (Paracetomal)-associated overdoses in the United StatesParivash Nourjah, Syed Rizwanuddin Ahmad, Claudia Karwoski, et al.
The American Journal of Medicine|April 12, 2003
Troglitazone-induced liver failure: a case studyDavid J Graham, Lanh Green, John R Senior, et al.
Journal of the American Pharmacists Association : Japha|July 26, 2008
Drug-risk communication to pharmacists: assessing the impact of risk-minimization strategies on the practice of pharmacyLauren Y Lee, Cindy M Kortepeter, Mary E Willy, et al.
The Annals of Pharmacotherapy|March 10, 2005
Factors associated with celecoxib and rofecoxib utilizationNigel S B Rawson, Parivash Nourjah, Stella C Grosser, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|August 5, 2005
Risk factors for prolonged QTc among US adults: Third National Health and Nutrition Examination SurveyStephen R Benoit, Aaron B Mendelsohn, Parivash Nourjah, et al.
Pharmacoepidemiology and Drug Safety|January 1, 2009
Emergency department visits attributed to selected analgesics, United States, 2004-2005Mary Willy, Judith P Kelly, Parivash Nourjah, et al.
Pageof 2